The St. Jude Children's Research Hospital ASHP-accredited Clinical Pharmacogenomics Residency is a one-year program that provides advanced training in clinical pharmacogenomics, an introduction to translational research, and organized experiences for the management of sophisticated pharmacy service programs. The clinical pharmacogenomics resident will be actively involved in providing clinical pharmacogenomics services to patients and will participate in various activities that promote the clinical implementation of pharmacogenomics at St. Jude and beyond. Required and elective clinical rotations provide the resident training in applied therapeutics, nutrition support and pediatric pharmacotherapy. The resident will be engaged in activities related to interpreting pharmacogenomic test results, writing translation algorithms to convert lab test results into meaningful diplotype interpretations, providing pharmacogenomic consults for patients that include recommendations for drug therapy, conducting a clinical trial, evaluating pharmacogenomics literature, and implementing clinical informatics based on pharmacogenomic results. Experience in teaching is acquired through providing lectures, in-services, journal club presentations, and precepting pharmacy students.
The pharmacogenomics resident will take the lead on writing a manuscript for publication in a peer-reviewed journal. The resident will write clinical decision support rules to flag high-risk drugs to high-risk diplotypes and will assist with the development of educational tools for patients, pharmacists, and other clinicians.
Requirements include a Doctor of Pharmacy degree, successful completion of a PGY1 residency, and license (or eligibility) to practice pharmacy in Tennessee. A background in biological sciences or basic human genetics is recommended.
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier basic science research center and one of the largest centers in the world for research and treatment of pediatric cancers and other catastrophic diseases of children. The hospital's mission is to find cures for children with catastrophic illness through research and treatment. The department's mission is to provide the highest quality comprehensive clinical pharmaceutical care to children with catastrophic diseases, always working to integrate research findings into clinical care as quickly as possible. The department consists of professional, technical, and support personnel - all focused on providing care across the inpatient/outpatient continuum. The Pharmaceutical Department includes an accredited clinical laboratory responsible for all clinical drug assays and comprehensive centralized and decentralized distributive and clinical pharmacy services, all supported by a fully integrated state-of-the-art electronic medical record, including CPOE. Departmental faculty and clinical staff are essential members of a laboratory-based clinical care and research program focusing on pediatric clinical therapeutics.